eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
3/2022
vol. 38
 
Share:
Share:
Case report

A rare case of a native aortic valve fungal endocarditis in a young woman

Łukasz Piątek
1
,
Karolina Piątek
1
,
Jacek Kurzawski
2
,
Szymon Domagała
1
,
Łukasz Turek
1
,
Zbigniew Starzyk
3
,
Edward Pietrzyk

1.
Collegium Medicum, Jan Kochanowski University, Kielce, Poland Head of the Collegium: Prof. Marianna Janion MD, PhD
2.
2nd Clinic of Cardiology, Swietokrzyskie Cardiology Centre, Kielce, Poland Head of the Clinic: Prof. Marianna Janion MD, PhD
3.
Cardiosurgery Clinic, Swietokrzyskie Cardiology Centre, Kielce, Poland Head of the Clinic: Edward Pietrzyk MD, PhD
Medical Studies/Studia Medyczne 2022; 38 (3): 245–248
Online publish date: 2022/09/30
Article file
- A rare case.pdf  [0.14 MB]
Get citation
 
PlumX metrics:
 

Introduction

Nowadays, bariatric surgery is the only procedure that can provide satisfactory long-term outcomes for people suffering from advanced obesity. However, this type of a surgical intervention is associated with a variety of early and late complications [1]. In this report we present a case study of fungal endocarditis, an exceptionally rare form of cardiac infection, resulting from complications of previous bariatric procedures.

Case report

A 37-year-old woman underwent a laparoscopic sleeve gastrectomy due to advanced obesity (body mass index (BMI) over 40 kg/m2). In the early postoperative period, an intraabdominal abscess formed in the epigastric area. For that reason, on the sixth day after the index procedure a reoperation was necessary – the abscess was evacuated, and the upper anastomosis was sutured. Three weeks later, an eventeration occurred and the patient underwent another laparotomy – the stomach was removed, and oesophageal intestinal Roux-en-Y anastomosis was performed. Finally, 2 months later, as a result of surgical wound suppuration, the infected tissues were resected, and the patient underwent abdominoplasty. In the course of the treatment the patient was administered various types of antibiotics: ceftriaxone, amoxicillin/clavulanic acid, metronidazole, amikacin, and meropenem. Six months after the index operation, the patient was admitted to our Cardiac Surgery Department from the local Cardiology Centre with an initial diagnosis of a myxoma based on echocardiographic examination. The patient had suffered from high fever (up to 40°C) and growing dyspnoea for 10 days, and the symptoms persisted despite empiric antibiotic administration. On admission to our centre the patient was in a serious clinical condition: febrile, diaphoretic, dyspnoeic with a significant tachycardia. Emergency echocardiography was performed, which revealed a large mass, probably vegetation, 37 × 20 mm in diameter, in connection with the left coronary leaflet of the aortic valve (AV), and with signs of severe aortic regurgitation (AR) with a shortened pressure half time (PHT) of 107 ms. There was also a moderate mitral regurgitation (secondary do severe AR) with no deviation in mitral valve (MV) morphology. Mild dilatation of the left ventricle (LVEDD – 65 mm, LVESD – 40 mm) was observed, with general hyperkinesis (Figures 1 A, B). The patient was qualified for an urgent surgery. During preparation a sudden cardiac arrest occurred. Immediate resuscitation, including defibrillation, was implemented, which resulted in a return of spontaneous circulation. The surgical procedure was carried out in cardiopulmonary bypass, in general hypothermia of 30°C with blood cardioplegia. After the aortotomy, a massive tumour placed within the left coronary leaflet (Figure 2) as well as an inflamed aortic valve annulus were removed, and an artificial aortic valve SJM 19A was implanted. After the surgery the patient demanded circulatory and respiratory support. Inotropic infusion along with diuretics was introduced. In the early postoperative period left hemiparesis along with aphasia emerged. Head computed tomography (CT) revealed a hypotensive lesion in the right frontoparietal area. Thanks to continued rehabilitation the symptoms have gradually subsided. Empiric antibiotic therapy consisting of vacomicin, gentamicin, metronidazole, and fluconazole was immediately introduced. Microbiological examination of the excised aortic valve vegetation as well as blood culture disclosed Candida albicans susceptible to fluconazole and voriconazole. Laboratory biomarkers of inflammatory response were significantly elevated (Figure 3). Despite the administered therapy, fever episodes were observed during the first few days after the surgery. In a week the patient was afebrile, the white blood count (WBC) as well as C-reactive protein (CRP) subsided, and controlled blood culture was negative. Fluconazole administration was changed to Voriconazole. Unfortunately, vision disturbances arose. An ophthalmology consultant confirmed the diagnosis of a fungal infection (subretinal lesion) of the right eye. Antifungal therapy was continued through 4 weeks. A CT scan of chest and abdomen did not reveal any potential source of a hidden infection. Postoperative echocardiography revealed no abnormalities: preserved contractility of left ventricle with ejection fraction (LVEF) over 50% and satisfactory aortic valve prosthesis function with prosthesis pressure gradient of 35/17 mm Hg. As soon as was possible, an oral anticoagulant was administered. Further hospitalization was uneventful, and the patient was discharged from the Cardiac Surgery ward after 4-week-long treatment in a stable condition.

Discussion

This case report presents an unusual native aortic valve Candida endocarditis in an immunocompetent patient. Infective endocarditis (IE) is one of the most challenging diagnoses, having many presentations, from indolent infection to septicaemia. The vast majority of IE cases are caused by various species of bacteria whereas fungal infection accounts only for 1% to 3% of all infective endocarditis cases. What is more, fungal endocarditis remains extremely rare in immunocompetent patients with native valves. Candida spp. is the most common pathogen, responsible for more than 50% of cases of fungal endocarditis. This kind type of infection has specific echocardiographic features like abnormally large vegetations, and it is associated with an exceptionally high mortality rate, ranging from 30% to 80% despite surgical and antifungal treatment. Candida spp. accounts only for 1–2% of all infective endocarditis (IE) cases. In the past it was predominantly observed in intravenous drug users. Nowadays it is strongly associated with a prosthetic valve or prior bacterial endocarditis. In many cases there is a long interval (over 1 year) between a previous episode or intervention to the manifestation of fungal endocarditis. Other important risk factors are immunosuppression (due to neutropaenia, transplants, solid tumour, or AIDS) and congestive heart failure. The majority of infections are acquired nosocomially [2–4]. The clinical presentation of Candida endocarditis includes septicaemia with a persistent fever (with resistance for empiric antibacterial therapy) and an extremely high risk of embolic complications, which is the most common reason for early surgical intervention. In addition, CE has specific echocardiographic features like abnormally large vegetations (often over 20 mm), which are usually hyperechogenic (dense) or heterogeneous. Local complications like abscesses or aneurysms are common. In many cases there is a notable discrepancy between the large size of the vegetation and a rather mild grade of the associated valve regurgitation. Quite often the vegetation adheres to paravalvular structures or interventricular septum [5]. In our case, the mass in the left ventricle outflow tract was exceptionally large (37 × 20 mm) and hyperechogenic, which is a characteristic feature of fungal vegetation. Despite the urgent surgery, our patient developed embolic complications, which is characteristic for fungal endocarditis. There is an obvious connection between the size and heterogenic structure of fungal vegetation and an extremely high risk of embolism [5]. Our patient, a 37-year-old woman, had no history of previous heart disease or immunosuppression. She was an obese person (BMI about 40 kg/m2 on admission). Six months before the admission she had undergone a bariatric surgery complicated by an infection in the operation area. Consequently, further surgical interventions as well as various antibiotics were administered. Follow-up was uneventful until sudden onset of endocarditis symptoms. Retrospective analysis of this case revealed that it was the only risk factor of the endocarditis. That is in accordance with previous reports – the majority of fungal infections are nowadays acquired nosocomially [2–4]. The patient displayed a favourable clinical course, responded well on the implemented treatment, and after 4 weeks of antifungal therapy she seemed to be cured. Unfortunately, a few months later, she died of an unknown cause. The mortality rate of Candida endocarditis is significantly higher than that of bacterial valve involvement. One of the latest analyses showed that in-hospital mortality is estimated at 36% while 1-year mortality is up to 59%. Paradoxically, mortality was not affected by use of surgical therapy or choice of antifungal agent [2]. Although fungal endocarditis is very rare in a clinical practice, especially in patients with no history of previous endocarditis or heart surgery, early diagnosis, surgical intervention, and prolonged antifungal therapy are necessary to save the patient’s life [6–10].

Conclusions

We present a rare case of native aortic valve fungal endocarditis in a young obese woman. Our patient had undergone a bariatric surgery followed by numerous local complications associated with further surgical procedures and multiple antibiotic treatment. Six months later, she was admitted to our centre with signs of septicaemia. In echocardiography a massive tumour on the aortic valve was revealed. An urgent cardiosurgery operation was performed – the tumour was resected, and an artificial valve was implanted. Microbiological analysis of the tumour and blood samples confirmed fungal infection (Candida albicans). Intensive antifungal therapy was continued for 4 weeks. However, during the hospitalization serious embolic complications were observed in the central nervous system and one eye. Finally, the patient displayed a favourable clinical course, responded well on the implemented treatment, and was discharged in a good clinical condition. Our case presents an exceptionally rare form of cardiac infection, unexpected in immunocompetent patients. We associate this condition with an unfavourable course of the previous bariatric therapies.

Acknowledgments

Project financed under the program the Minister of Education and Science called “Regional Initiative of Excellence” in the years 2019-2022, project no. 024/RID/2018/19, amount of financing 11 999 000,00 PLN.

Conflict of interest

The authors declare no conflict of interest.

References

1. Ukleja A, Stone RL. Medical and gastroenterologic managment of the post-bariatric surgery patent. J Clin Gastroenterol 2004; 38: 321.
2. Arnold CJ, Johnson M, Bayer AS, Bradley S, Giannitsioti E. Candida infective endocarditis: an observational cohort study with a focus on therapy. Antimicrob Agents Chemother 2015; 59: 2365-2373.
3. Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect 2012; 18: E99-E109.
4. Badiee P, Amirghofran AA, Ghazi Nour M, Shafa M, Nemati MH. Incidence and outcome of documented fungal endocarditis. Int Cardiovasc Res J 2014; 8: 152-155.
5. Donal E, Abgueguen P, Coisne D, Gouello JP, McFad- den EP. Echocardiographic features of Candida species endocarditis: 12 cases and a review of published reports. Heart 2001; 86: 179-182.
6. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventu- ra W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001; 32: 50-62.
7. Toyoda S, Tajima E, Fukuda R, Masawa T, Inami S. Early surgical intervention and optimal medical treatment for Candida parapsilosis endocarditis. Intern Med 2015; 54: 411-413.
8. Ganesan V, Kumar GS, Ponnusamy SS. Candida endocarditis: the insidious killer. J Glob Infect Dis 2015; 7: 48-50.
9. Chaudhary SC, Sawlani KK, Arora R, Kumar V. Native aortic valve fungal endocarditis. BMJ Case Rep 2013; 2013: bcr2012007144.
10. Pelemiš M, Stevanović G, Lavadinović L, Matić S, Milošević I. A rare case of Candida parapsilosis endocarditis in a young healthy woman: case report. J Cardiothorac Surg 2013; 8: 29.
Copyright: © 2022 Jan Kochanowski University in Kielce This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.